| Diamond-Blackfan anemia, the archetype of ribosomopathy: How distinct is it from the other constitutional ribosomopathies? |
L. Da Costa, Jessica Platon |
01/01/24
|
Blood Cells, Molecules, and Diseases |
| Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study |
Cyril Quivoron, H. Lecourt, Vincent Ribrag |
01/01/24
|
Leukemia and Lymphoma |
| Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology |
Jean Marie Michot |
11/01/23
|
European Journal of Cancer |
| The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions |
Elia Henry, Vilma Barroca, Nathalie Dechamps, Francoise Pflumio, Marie Laure Arcangeli |
10/01/23
|
Stem cells translational medicine |
| FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations |
Patrycja Pawlikowska, Alessia Oppezzo, Filippo Rosselli |
09/08/23
|
Oncogene |
| Exploring the genetic landscape of HCV-related B-cell lymphomas using whole exome sequencing |
Jean Marie Michot |
06/01/23
|
Leukemia |
| The NFIA-ETO2 fusion blocks erythroid maturation and induces pure erythroid leukemia in cooperation with mutant TP53 |
Alexandre Fagnan, Thomas Mercher |
05/04/23
|
Blood |
| Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 study |
Jean Marie Michot, Clémentine Sarkozy, Olivier A. Bernard, Vincent Ribrag |
04/01/23
|
American Journal of Hematology |
| From normal hematopoiesis to malignancies: Highlights from the 2021 Meeting of the Club Hematopoiesis and Oncogenesis |
Adlen Foudi |
03/01/23
|
Bulletin du Cancer |
| High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia |
Zakia Aid, Elie Robert, Cécile K. Lopez, Fabien Boudia, Melchior Le Mene, Julie Riviere, Marie Baille, Salima Benbarche, Alexandre Fagnan, Cécile Thirant, Laetitia Federici, Muriel Gaudry, Camille Lobry, Thomas Mercher |
03/01/23
|
Leukemia |
| Precision Medicine Approach Based on Molecular Alterations for Patients with Relapsed or Refractory Multiple Myeloma: Results from the MM-EP1 Study |
Cyril Quivoron, Olivier A. Bernard, Vincent Ribrag, Jean Marie Michot |
03/01/23
|
Cancers |
| Targeting M2 Macrophages with a Novel NADPH Oxidase Inhibitor |
Stéphanie Solier |
02/01/23
|
Antioxidants |
| Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues |
Gérard Pierron |
02/01/23
|
International Journal of Molecular Sciences |
| Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors |
Jean Marie Michot |
01/01/23
|
European Journal of Cancer |
| GWAS meta-analysis of intrahepatic cholestasis of pregnancy implicates multiple hepatic genes and regulatory elements |
Remi Favier |
12/01/22
|
Nature Communications |
| HDAC1 and PRC2 mediate combinatorial control in SPI1/PU.1-dependent gene repression in murine erythroleukaemia |
Sebastian Gregoricchio, Michela Esposito, Laure Delestré, M’boyba Khadija Diop, Christel Guillouf |
08/12/22
|
Nucleic Acids Research |
| Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma |
Cyril Quivoron, Vincent Ribrag, Clémentine Sarkozy |
08/01/22
|
Haematologica |
| Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model |
Brahim Arkoun, Stefania Mazzi, Mathieu Vieira, Imanci Aygun, Nathalie Droin, Najet Debili, Isabelle Plo, Hana Raslova, William Vainchenker |
07/15/22
|
Journal of Clinical Investigation |
| Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia |
Salima Benbarche, Cécile K. Lopez, Zakia Aid, Cécile Thirant, Marie Charlotte Laiguillon, Séverine Lecourt, Marion Antonini, Jiang Hu, Thomas Mercher, Camille Lobry |
02/01/22
|
Science advances |
| RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis |
Eric Solary, Nathalie Droin |
12/01/21
|
Nature Communications |
